期刊
NEUROBIOLOGY OF AGING
卷 57, 期 -, 页码 47-63出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2017.04.022
关键词
Alzheimer; Tau; Aggregation; Cell death; Inhibitor
资金
- DZNE
- MPG
- Tau Consortium
The aggregation of Tau protein is a hallmark of neurodegenerative diseases including Alzheimer's disease. Previously, we generated a cell model of tauopathy based on the 4-repeat domain with the FTDP-17 mutation Delta K280 (Tau(4RDDK)) which is expressed in a regulatable fashion (tet-on). The deletion variant Delta K280 is highly amyloidogenic and forms fibrous aggregates in neuroblastoma N2a cells staining with the reporter dye Thioflavin S. The aggregation of Tau(4RDDK) is toxic, contrary to wildtype or anti-aggregant variants of the protein. Using a novel approach for monitoring in situ Tau aggregation and toxicity by combination of microscopic analysis with FACS and biochemical analysis of cells enabled the dissection of the aggregating species which cause a time-dependent increase of toxicity. The dominant initiating step is the dimerization of Tau(4RDDK) which leads to further aggregation and induces a strong increase in reactive oxygen species (ROS) and cytoplasmic Ca2+ which damage the membranes and cause cell death. Tau-based treatments using Tau aggregation inhibitors reduce both soluble oligomeric and fully aggregated Tau species and decrease their toxicity. (C) 2017 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据